Cardiovascular Abnormalities in Children With Attention-deficit/Hyperactivity Disorder (NCT07655843) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Cardiovascular Abnormalities in Children With Attention-deficit/Hyperactivity Disorder
100 participantsStarted 2026-06-15
Plain-language summary
To identify the prevalence and types of cardiovascular abnormalities in children diagnosed with ADHD
Who can participate
Age range
6 Years – 18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Case group :
* Age is \> 6 years and \<18 years old
* Both sex
* Patients diagnosed as having ADHD according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.
* Currently receiving pharmacological treatment for at least six months
Control group:
Healthy, typically developing children , matched by age and sex to the case group
\-
Exclusion Criteria:
* Age \> 18 years
* Patients who have a history of chronic diseases.
* Patients with established hereditary syndromes or chromosomal abnormalities as Down syndrome.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study is specifically looking at ECG and echocardiographic abnormalities in children with ADHD — should my child have a heart evaluation before we consider ADHD medications, and is this trial a way to get that done?
2Since this trial isn't recruiting yet, how soon do you think it might open, and is there any reason we should wait for it rather than moving forward with standard evaluation and treatment now?
3The study is measuring blood pressure alongside heart rhythm and structure — does my child's current blood pressure put them at any particular risk that this kind of cardiovascular screening would be important to catch?
4This appears to be an observational study rather than a treatment trial — what does that mean for my child in practical terms, and what would actually happen during their participation?
5If this study finds cardiovascular abnormalities are common in children with ADHD, how might that change the way you'd approach prescribing stimulant or non-stimulant medications for my child?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
prevalence of ECG and echocardiographic abnormalities in children with ADHD.